Skip to main content
Top
Published in: BMC Medicine 1/2022

01-12-2022 | Myocardial Infarction | Research article

Length of initial prescription at hospital discharge and long-term medication adherence for elderly, post-myocardial infarction patients: a population-based interrupted time series study

Authors: J. D. Schwalm, Noah M. Ivers, Zachary Bouck, Monica Taljaard, Madhu K. Natarajan, Francis Nguyen, Waseem Hijazi, Kednapa Thavorn, Lisa Dolovich, Tara McCready, Erin O’Brien, Jeremy M. Grimshaw

Published in: BMC Medicine | Issue 1/2022

Login to get access

Abstract

Background

Preliminary evidence suggests that providing longer duration prescriptions at discharge may improve long-term adherence to secondary preventative cardiac medications among post-myocardial infarction (MI) patients. We implemented and assessed the effects of two hospital-based interventions—(1) standardized prolonged discharge prescription forms (90-day supply with 3 repeats for recommended cardiac medications) plus education and (2) education only—on long-term cardiac medication adherence among elderly patients post-MI.

Methods

We conducted an interrupted time series study of all post-MI patients aged 65–104 years in Ontario, Canada, discharged from hospital between September 2015 and August 2018 with ≥ 1 dispensation(s) for a statin, beta blocker, angiotensin system inhibitor, and/or secondary antiplatelet within 7 days post-discharge. The standardized prolonged discharge prescription forms plus education and education-only interventions were implemented at 2 (1,414 patients) and 4 (926 patients) non-randomly selected hospitals in September 2017 for 12 months, with all other Ontario hospitals (n = 143; 18,556 patients) comprising an external control group. The primary outcome, long-term cardiac medication adherence, was defined at the patient-level as an average proportion of days covered (over 1-year post-discharge) ≥ 80% across cardiac medication classes dispensed at their index fill. Primary outcome data were aggregated within hospital groups (intervention 1, 2, or control) to monthly proportions and independently analyzed using segmented regression to evaluate intervention effects. A process evaluation was conducted to assess intervention fidelity.

Results

At 12 months post-implementation, there was no statistically significant effect on long-term cardiac medication adherence for either intervention—standardized prolonged discharge prescription forms plus education (5.4%; 95% CI − 6.4%, 17.2%) or education only (1.0%; 95% CI − 28.6%, 30.6%)—over and above the counterfactual trend; similarly, no change was observed in the control group (− 0.3%; 95% CI − 3.6%, 3.1%). During the intervention period, only 10.8% of patients in the intervention groups received ≥ 90 days, on average, for cardiac medications at their index fill.

Conclusions

Recognizing intervention fidelity was low at the pharmacy level, and no statistically significant post-implementation differences in adherence were found, the trends in this study—coupled with other published retrospective analyses of administrative data—support further evaluation of this simple intervention to improve long-term adherence to cardiac medications.

Trial registration

ClinicalTrials.​gov: NCT03257579, registered June 16, 2017
Appendix
Available only for authorised users
Literature
1.
go back to reference Smith SC Jr, Benjamin EJ, Bonow RO, Braun LT, Creager MA, Franklin BA, et al. AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation. Circulation. 2011;124:2458. https://doi.org/10.1161/CIR.0b013e318235eb4d.CrossRefPubMed Smith SC Jr, Benjamin EJ, Bonow RO, Braun LT, Creager MA, Franklin BA, et al. AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation. Circulation. 2011;124:2458. https://​doi.​org/​10.​1161/​CIR.​0b013e318235eb4d​.CrossRefPubMed
2.
go back to reference Antman EM, Hand M, Armstrong PW, Bates ER, Green LA, Halasyamani LK, et al. 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association task force on practice guidelines: developed in collaboration with the Canadian cardiovascular society endorsed by the American Academy of family physicians: 2007 writing group to review new evidence and update the ACC/AHA 2004 guidelines for the Management of Patients with ST-elevation myocardial infarction, writing on behalf of the 2004 writing committee. Circulation. 2008;117:296.CrossRefPubMed Antman EM, Hand M, Armstrong PW, Bates ER, Green LA, Halasyamani LK, et al. 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association task force on practice guidelines: developed in collaboration with the Canadian cardiovascular society endorsed by the American Academy of family physicians: 2007 writing group to review new evidence and update the ACC/AHA 2004 guidelines for the Management of Patients with ST-elevation myocardial infarction, writing on behalf of the 2004 writing committee. Circulation. 2008;117:296.CrossRefPubMed
3.
go back to reference Fitchett DH, Theroux P, Brophy JM, Cantor WJ, Cox JL, Gupta M, et al. Assessment and management of acute coronary syndromes (ACS): a Canadian perspective on current guideline-recommended treatment—part 2: ST-segment elevation myocardial infarction. Can J Cardiol. 2011;27(Suppl A):S402.CrossRefPubMed Fitchett DH, Theroux P, Brophy JM, Cantor WJ, Cox JL, Gupta M, et al. Assessment and management of acute coronary syndromes (ACS): a Canadian perspective on current guideline-recommended treatment—part 2: ST-segment elevation myocardial infarction. Can J Cardiol. 2011;27(Suppl A):S402.CrossRefPubMed
4.
go back to reference Ivers NM, Schwalm JD, Jackevicius CA, Guo H, Tu JV, Natarajan M. Length of initial prescription at hospital discharge and long-term medication adherence for elderly patients with coronary artery disease: a population-level study. Can J Cardiol. 2013;29:1408.CrossRefPubMed Ivers NM, Schwalm JD, Jackevicius CA, Guo H, Tu JV, Natarajan M. Length of initial prescription at hospital discharge and long-term medication adherence for elderly patients with coronary artery disease: a population-level study. Can J Cardiol. 2013;29:1408.CrossRefPubMed
5.
go back to reference Tu JV, Donovan LR, Lee DS, Wang JT, Austin PC, Alter DA, et al. Effectiveness of public report cards for improving the quality of cardiac care: the EFFECT study: a randomized trial. JAMA. 2009;302:2330.CrossRefPubMed Tu JV, Donovan LR, Lee DS, Wang JT, Austin PC, Alter DA, et al. Effectiveness of public report cards for improving the quality of cardiac care: the EFFECT study: a randomized trial. JAMA. 2009;302:2330.CrossRefPubMed
6.
go back to reference Ahmad M, Schwalm JD, Velianou JL, Natarajan MK. Impact of routine in-hospital assessment of low-density lipoprotein levels and standardized orders on statin therapy in patients undergoing percutaneous coronary interventions. J Invasive Cardiol. 2005;17:518.PubMed Ahmad M, Schwalm JD, Velianou JL, Natarajan MK. Impact of routine in-hospital assessment of low-density lipoprotein levels and standardized orders on statin therapy in patients undergoing percutaneous coronary interventions. J Invasive Cardiol. 2005;17:518.PubMed
7.
go back to reference Newby LK, Allen Lapointe NM, Chen AY, Kramer JM, Hammill BG, Delong ER, et al. Long-term adherence to evidence-based secondary prevention therapies in coronary artery disease. Circulation. 2006;113:203.CrossRefPubMed Newby LK, Allen Lapointe NM, Chen AY, Kramer JM, Hammill BG, Delong ER, et al. Long-term adherence to evidence-based secondary prevention therapies in coronary artery disease. Circulation. 2006;113:203.CrossRefPubMed
8.
go back to reference Hudson M, Richard H, Pilote L. Parabolas of medication use and discontinuation after myocardial infarction—are we closing the treatment gap? Pharmacoepidemiol Drug Saf. 2007;16:773.CrossRefPubMed Hudson M, Richard H, Pilote L. Parabolas of medication use and discontinuation after myocardial infarction—are we closing the treatment gap? Pharmacoepidemiol Drug Saf. 2007;16:773.CrossRefPubMed
9.
go back to reference Shah ND, Dunlay SM, Ting HH, Montori VM, Thomas RJ, Wagie AE, et al. Long-term medication adherence after myocardial infarction: experience of a community. Am J Med. 2009;122:961.e7–961.e13.CrossRef Shah ND, Dunlay SM, Ting HH, Montori VM, Thomas RJ, Wagie AE, et al. Long-term medication adherence after myocardial infarction: experience of a community. Am J Med. 2009;122:961.e7–961.e13.CrossRef
10.
go back to reference Rasmussen JN, Chong A, Alter DA. Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction. JAMA. 2007;297:177.CrossRefPubMed Rasmussen JN, Chong A, Alter DA. Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction. JAMA. 2007;297:177.CrossRefPubMed
11.
go back to reference Ho PM, Magid DJ, Shetterly SM, Olson KL, Maddox TM, Peterson PM, et al. Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery disease. Am Heart J. 2008;155:772.CrossRefPubMed Ho PM, Magid DJ, Shetterly SM, Olson KL, Maddox TM, Peterson PM, et al. Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery disease. Am Heart J. 2008;155:772.CrossRefPubMed
12.
go back to reference Ho PM, Bryson CL, Rumsfeld JS. Medication adherence: its importance in cardiovascular outcomes. Circulation. 2009;119:3028.CrossRefPubMed Ho PM, Bryson CL, Rumsfeld JS. Medication adherence: its importance in cardiovascular outcomes. Circulation. 2009;119:3028.CrossRefPubMed
13.
go back to reference Sabate E, editor. Adherence to long-term therapies: evidence for action. Geneva: World Health Organization; 2003. Sabate E, editor. Adherence to long-term therapies: evidence for action. Geneva: World Health Organization; 2003.
14.
go back to reference Spertus JA, Kettelkamp R, Vance C, Decker C, Jones PG, Rumsfeld JM, et al. Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry. Circulation. 2006;113:2803.CrossRefPubMed Spertus JA, Kettelkamp R, Vance C, Decker C, Jones PG, Rumsfeld JM, et al. Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry. Circulation. 2006;113:2803.CrossRefPubMed
15.
go back to reference Hope CJ, Wu J, Tu W, Young J, Murray MD. Association of medication adherence, knowledge, and skills with emergency department visits by adults 50 years or older with congestive heart failure. Am J Health Syst Pharm. 2004;61:2043.CrossRefPubMed Hope CJ, Wu J, Tu W, Young J, Murray MD. Association of medication adherence, knowledge, and skills with emergency department visits by adults 50 years or older with congestive heart failure. Am J Health Syst Pharm. 2004;61:2043.CrossRefPubMed
16.
go back to reference Batal HA, Krantz MJ, Dale RA, Mehler PS, Steiner JF. Impact of prescription size on statin adherence and cholesterol levels. BMC Health Serv Res. 2007;7:175 PMID: 17961256.CrossRefPubMedPubMedCentral Batal HA, Krantz MJ, Dale RA, Mehler PS, Steiner JF. Impact of prescription size on statin adherence and cholesterol levels. BMC Health Serv Res. 2007;7:175 PMID: 17961256.CrossRefPubMedPubMedCentral
17.
go back to reference Steiner JF, Robbins LJ, Roth SC, Hammond WS. The effect of prescription size on acquisition of maintenance medications. J Gen Intern Med. 1993;8:306.CrossRefPubMed Steiner JF, Robbins LJ, Roth SC, Hammond WS. The effect of prescription size on acquisition of maintenance medications. J Gen Intern Med. 1993;8:306.CrossRefPubMed
19.
go back to reference Presseau J, Schwalm JD, Grimshaw JM, Witteman HO, Natarajan MK, Linklater S, et al. Identifying determinants of medication adherence following myocardial infarction using the theoretical domains framework and the health action process approach. Psychol Health. 2017;32(10):1176–94.CrossRefPubMed Presseau J, Schwalm JD, Grimshaw JM, Witteman HO, Natarajan MK, Linklater S, et al. Identifying determinants of medication adherence following myocardial infarction using the theoretical domains framework and the health action process approach. Psychol Health. 2017;32(10):1176–94.CrossRefPubMed
20.
go back to reference Lau E, Papaioannou A, Dolovich L, Adachi J, Sawka AM, Burns S, et al. Patients’ adherence to osteoporosis therapy: exploring the perceptions of postmenopausal women. Can Fam Physician. 2008;54:394.PubMed Lau E, Papaioannou A, Dolovich L, Adachi J, Sawka AM, Burns S, et al. Patients’ adherence to osteoporosis therapy: exploring the perceptions of postmenopausal women. Can Fam Physician. 2008;54:394.PubMed
21.
go back to reference Dolovich L, Nair K, Sellors C, Lohfeld L, Lee A, Levine M. Do patients’ expectations influence their use of medication? Can Fam Physician. 2008;54(3):384.PubMedPubMedCentral Dolovich L, Nair K, Sellors C, Lohfeld L, Lee A, Levine M. Do patients’ expectations influence their use of medication? Can Fam Physician. 2008;54(3):384.PubMedPubMedCentral
22.
go back to reference Ministry of Health: Drugs and Devices Division. Section 5: standard online claims. In: Ontario drug programs reference manual (edition 2, 45-48). Queen’s printer for Ontario; 2021. Ministry of Health: Drugs and Devices Division. Section 5: standard online claims. In: Ontario drug programs reference manual (edition 2, 45-48). Queen’s printer for Ontario; 2021.
23.
go back to reference Schwalm JD, Ivers NM, Natarajan MK, Taljaard M, Rao-Melocini P, Witteman HO, et al. Cluster randomized controlled trial of delayed educational reminders for long-term medication adherence in ST-elevation myocardial infarction (DERLA-STEMI). Am Heart J. 2015;170:903.CrossRefPubMed Schwalm JD, Ivers NM, Natarajan MK, Taljaard M, Rao-Melocini P, Witteman HO, et al. Cluster randomized controlled trial of delayed educational reminders for long-term medication adherence in ST-elevation myocardial infarction (DERLA-STEMI). Am Heart J. 2015;170:903.CrossRefPubMed
24.
go back to reference Schwalm JD, Ivers NM, Bouck Z, Taljaard M, Natarajan MK, Dolovich L, et al. Length of initial prescription at hospital discharge and long-term medication adherence for elderly, post-myocardial infarction patients: protocol for an interrupted time series study. JMIR Res Protoc. 2020;9(11):e18981.CrossRefPubMedPubMedCentral Schwalm JD, Ivers NM, Bouck Z, Taljaard M, Natarajan MK, Dolovich L, et al. Length of initial prescription at hospital discharge and long-term medication adherence for elderly, post-myocardial infarction patients: protocol for an interrupted time series study. JMIR Res Protoc. 2020;9(11):e18981.CrossRefPubMedPubMedCentral
26.
go back to reference Turner SL, Karahalios A, Forbes AB, Taljaard M, Grimshaw JM, Cheng AC, et al. Design characteristics and statistical methods used in interrupted time series studies evaluating public health interventions: a review. J Clin Epidemiol. 2020;122:1–11.CrossRefPubMed Turner SL, Karahalios A, Forbes AB, Taljaard M, Grimshaw JM, Cheng AC, et al. Design characteristics and statistical methods used in interrupted time series studies evaluating public health interventions: a review. J Clin Epidemiol. 2020;122:1–11.CrossRefPubMed
27.
go back to reference Kozma CM, Dickson M, Phillips AL, Meletiche DM. Medication possession ratio: implications of using fixed and variable observation periods in assessing adherence with disease-modifying drugs in patients with multiple sclerosis. Patient Prefer Adherence. 2013;12(7):509–16.CrossRef Kozma CM, Dickson M, Phillips AL, Meletiche DM. Medication possession ratio: implications of using fixed and variable observation periods in assessing adherence with disease-modifying drugs in patients with multiple sclerosis. Patient Prefer Adherence. 2013;12(7):509–16.CrossRef
29.
go back to reference Choudhry NK, Kronish IM, Vongpatanasin W, Ferdinand KC, Pavlik VN, Egan BM, et al. Medication adherence and blood pressure control: a scientific statement from the American Heart Association. Hypertension. 2021;79(1):e1–e14.PubMed Choudhry NK, Kronish IM, Vongpatanasin W, Ferdinand KC, Pavlik VN, Egan BM, et al. Medication adherence and blood pressure control: a scientific statement from the American Heart Association. Hypertension. 2021;79(1):e1–e14.PubMed
31.
go back to reference Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2008;2:CD000011. Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2008;2:CD000011.
Metadata
Title
Length of initial prescription at hospital discharge and long-term medication adherence for elderly, post-myocardial infarction patients: a population-based interrupted time series study
Authors
J. D. Schwalm
Noah M. Ivers
Zachary Bouck
Monica Taljaard
Madhu K. Natarajan
Francis Nguyen
Waseem Hijazi
Kednapa Thavorn
Lisa Dolovich
Tara McCready
Erin O’Brien
Jeremy M. Grimshaw
Publication date
01-12-2022
Publisher
BioMed Central
Published in
BMC Medicine / Issue 1/2022
Electronic ISSN: 1741-7015
DOI
https://doi.org/10.1186/s12916-022-02401-5

Other articles of this Issue 1/2022

BMC Medicine 1/2022 Go to the issue